Page last updated: 2024-09-04

docetaxel anhydrous and Alopecia

docetaxel anhydrous has been researched along with Alopecia in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's19 (23.46)18.2507
2000's36 (44.44)29.6817
2010's19 (23.46)24.3611
2020's7 (8.64)2.80

Authors

AuthorsStudies
Accetta, C; Carbognin, L; D'Angelo, T; Di Giorgio, D; Di Leone, A; Fabi, A; Franceschini, G; Fuso, P; Garganese, G; Giannarelli, D; Magno, S; Masetti, R; Muratore, M; Paris, I; Pavese, F; Sanchez, AM; Scambia, G; Terribile, DA; Tiberi, G1
Heibloem, RE; Ilozumba, OUC; Komen, MMC; van den Hurk, CJG1
Dimitsaki, S; Jaulent, MC; Natsiavas, P1
Brunken, L; Hassan, N; Jackson, J; Mellor, C; Mitchell, E; Ng'andu, K; O'Brien, A; Paus, R; Purba, TS; Shahmalak, A; Smart, E1
Ben Kridis, W; Khanfir, A1
Alizadeh, N; Darjani, A; Mirpour, SH; Mohammadhoseini, M; Rafiei, E; Rafiei, R1
Bermejo, B; de la Torre-Montero, JC; Del Monte-Millán, M; García-Sáenz, JÁ; González-Neira, A; Herraez, B; Lluch, A; Martín, M; Núñez-Torres, R; Peiró-Chova, L; Pinilla, K; Pita, G; Rodrigo-Faus, M; Tejera-Pérez, H1
Ayari, J; Balti, M; Ben Abdallah, I; Ben Hassen, M; Ben Nasr, S; Doghri, Y; Fendri, S; Haddaoui, A; Trigui, E; Zribi, A1
DeLuca, AN; Esserman, LJ; Melisko, ME; Rice, BA; Rugo, HS; Ver Hoeve, ES1
Cheng, M; Qi, Y; Shi, J; Song, Z; Wang, M; Wang, X; Zhang, L1
Gao, B; Jiang, L; Jiang, X; Li, Y; Luo, D; Tang, Y; Wang, C; Yu, F; Zou, J1
Anchisi, S; Betticher, DC; Bodenmann, S; Breitenstein, U; Bühler, V; Delmore, G; Hügli-Dayer, AM; Müller, A; Schefer, H; Trueb, RR; von Moos, R; Zimmerli-Schwab, B1
Gu, QP; Guo, W; Li, ZP; Meng, J; Meng, QF; Si, YM; Zhang, J; Zhuang, QW1
Cathomas, R; De Bono, JS; Gillessen, S; Omlin, A; Rothermundt, C; Sartor, O; Shen, L; Su, Z1
Chuang, E; Cigler, T; Fiederlein, B; Isseroff, D; Moore, A; Schneider, S; Vahdat, L1
Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Legdeur, MC; Meulendijks, D; Schellens, JH1
Breed, WP; Goey, SH; Komen, MM; Nortier, JW; Smorenburg, CH; van den Hurk, CJ; van der Hoeven, JJ; van der Ploeg, T1
Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E1
Altundag, K; Barnadas, A; Botha, M; Chan, A; Cinieri, S; Coskun, U; Dodyk, P; Lazzarelli, S; Rauch, D; Tubiana-Mathieu, N; Vandebroek, A; Villanova, G1
Ding, G; Fu, Q; Ren, H; Su, FX; Wang, N; Wang, YJ; Wu, Q; Yang, JQ; Ye, ZB; Zhang, J; Zhou, LZ1
Matard, B; Pinquier, L; Prevezas, C; Reygagne, P1
El Bary, NM; El Halim Mohamed Abu Hamar, A; El Shebiney, M; Mansour, S; Maria, A; Sadaka, E1
Fanti, PA; Misciali, C; Miteva, M; Romanelli, P; Tosti, A; Vincenzi, C1
Daga, H; Hida, T; Horio, Y; Ishikawa, S; Kobayashi, K; Shimizu, J; Takeda, K; Tokunaga, S1
Breed, WP; Nortier, JW; van den Hurk, CJ1
Bessis, D; Dereure, O; Frouin, E; Guillot, B; Jacot, W; Kluger, N; Poujol, S; Rigau, V; Romieu, G1
Fan, Y; Li, Q; Ma, F; Wang, JY; Wang, WM; Xu, BH; Yuan, P; Zhang, P1
Cai, YL; Fan, XD; Guo, W; He, Y; Hu, YJ; Ji, T; Kies, MS; Lee, JJ; Li, J; Myers, JN; Ren, GX; Sun, J; Tu, WY; Wang, BS; Wang, LZ; Wang, YA; Wang, ZH; William, WN; Xu, LQ; Yang, WJ; Ye, WM; Zhang, CP; Zhang, ZY; Zhong, LP; Zhu, HG1
Siderov, J1
Archibald, H; Hutcheon, A; Macduff, C; Mackenzie, T; Melville, L1
Hihara, J; Minami, K; Ohta, K; Tanabe, K; Toge, T; Yamaguchi, Y; Yoshida, K1
Acquati, M; Ardizzoia, A; Casartelli, C; Fagnani, D; Fusco, O; Giordano, M; Malugani, F; Quattrone, A; Scanni, A; Tagliabue, P; Vergani, C; Visini, M1
Bonsignori, M; Marcucci, F; Massacesi, C; Mazzanti, P; Pilone, A; Rocchi, MB1
Akaza, H; Hattori, K; Hinotsu, S; Kawai, K; Kojima, T; Miyanaga, N; Onozawa, M; Shimazui, T; Tsukamoto, S1
Misawa, A; Misawa, H; Saitou, M; Ueta, K; Yasuda, M1
Antoniou, N; Bamias, A; Bozas, G; Deliveliotis, C; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostakopoulos, A; Papadimitriou, C; Skarlos, D1
Bagaméri, A; Lehoczky, O; Pulay, T; Sárosi, Z; Thurzó, L; Udvary, J1
Fujii, K; Fujino, S; Higashide, S; Hori, T; Inamoto, T; Kan, N; Lee, CJ; Maruhashi, K; Mise, K; Mitsumori, M; Nishimura, S; Okamoto, M; Okamura, T; Sawai, S; Takemoto, Y; Yamauchi, A1
Fukuda, M; Hatakeyama, S; Kashiwagi, R; Miyamoto, Y; Miyoshi, K; Murayama, D; Musashi, T; Nagai, H; Nanjo, H; Ohnuki, T; Yamaoka, K1
Hamada, K; Kubota, K; Mori, S; Nakagawa, A; Suzuki, N; Tagaya, N1
Ford, HE; Hall, M; Harries, M; Johnston, SR; Makris, A; Miles, DW; Miller, L; Smith, IE; Yap, YS1
Cao, Y; Feng, FY; Guan, ZZ; Guo, Y; Hu, XH; Tang, GD; Wang, ZQ; Xiong, JP; Zhang, L1
Akamatsu, H; Imazu, Y; Koshida, Y; Motegi, K; Murayama, T; Ohyama, R; Toeda, H; Toriumi, F; Yoneyama, K1
Hata, Y; Taguchi, K; Takahashi, H; Takahashi, M; Tamura, M; Todo, S; Watanabe, K1
Gao, YJ; Guan, XQ; Li, EX; Liu, JW; Nan, KJ; Sheng, LJ; Song, SP; Sun, Y; Wang, DL; Wang, XW; Wang, ZP; Wang, ZX; Yu, XJ; Zhang, MH; Zhang, XR1
Feng, FY; Guan, ZZ; Guo, Y; Hu, XH; Liu, DG; Peng, RJ; Tang, GD; Xiong, JP; Zhao, HY1
Iwabuchi, H; Nakayama, S; Uchiyama, K1
Endo, K; Fujii, K; Ikeda, T; Mashino, K; Ninomiya, M; Sakata, H; Shibahara, K; Tashiro, H1
Chahine, GY; Farhat, FS; Ghosn, MG; Kattan, JG; Moukadem, WT; Nasr, FL; Yazbeck, NJ; Younes, FC1
Akaza, H; Harabayashi, T; Hoshi, S; Koga, H; Naito, S; Sumiyoshi, Y; Tsukamoto, T1
Andreetta, C; Cardellino, GG; Crivellari, D; Damante, G; Di Loreto, C; Lombardi, D; Magri, MD; Mansutti, M; Minisini, AM; Perin, T; Puglisi, F; Russo, S; Veronesi, A1
Albanell, J; Awada, A; Baselga, J; Canney, PA; Cardoso, F; Dirix, LY; Gascon, P; Gil, T; Piccart, MJ1
Bessa, EH; Bonneterre, J; Genouville, C; Lemenager, M1
Abe, S; Fujii, M; Furuse, K; Inoue, Y; Kurita, Y; Oizumi, K; Onoshi, T; Sato, K; Sugiura, T; Watanabe, K1
Ariyoshi, Y; Fukuoka, M; Furue, H; Furuse, K; Hasegawa, K; Ishitani, K; Kanamaru, R; Niitani, H; Noda, K; Taguchi, T1
Catimel, G; Clavel, M; Franklin, H; Hanauske, A; Kaye, SB; Le Bail, N; Mattijssen, V; Piccart, M; Verweij, J; Wanders, J1
Taguchi, T1
Adachi, I; Hirata, K; Kitajima, M; Kunii, Y; Sano, M; Shimada, H; Suwa, T; Tabei, T; Taguchi, T; Tominaga, T1
Kurita, Y; Minoda, S; Nakano, M; Negoro, S; Niitani, H; Ogura, T; Taguchi, T; Watanabe, K; Yokoyama, A1
Arita, K; Fujita, A; Hino, M; Igarashi, T; Kudo, S; Niitani, H; Taguchi, T1
Abe, R; Enomoto, K; Fujita, M; Hamano, K; Hasegawa, K; Mori, S; Morishita, Y; Sasaki, Y; Tabei, T; Taguchi, T1
Adachi, I; Aoyama, H; Horikoshi, N; Narabayashi, M; Taguchi, T; Takashima, S; Watanabe, T1
Battafarano, DF; Burris, HA; Keeling, JH; Older, SA; Zimmerman, GC1
Ebbert, LP; Edmonson, JH; Gerstner, JB; Jung, SH; McGaw, H; Nascimento, AG1
Bessa, E; Bonneterre, J; Bonneterre, ME; Dauba, J; Lecomte, S; Lemenager, M1
Eisenhauer, EA; Vermorken, JB1
Kokawa, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G1
Eckhardt, S1
Hirabayashi, N; Kanamaru, R; Kurihara, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T1
Furue, H; Hirabayashi, N; Kanamaru, R; Kurihara, M; Mai, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T1
Abe, R; Kimijima, I; Ohtake, T; Sagara, H; Tsuchiya, A; Watanabe, T1
Beijnen, JH; Bult, A; Huizing, MT; Lustig, V; Rodenhuis, S; Rosing, H; Schellens, JH; ten Bokkel Huinink, WW; van Warmerdam, LJ1
Bamias, A; Katsimbri, P; Pavlidis, N1
Gordon, RJ; Osterwalder, B; Planting, AS; Pronk, LC; Reigner, B; Sparreboom, A; Twelves, C; Vasey, P; Verweij, J1
Chen, YM; Chou, KC; Lee, YC; Perng, RP; Shih, JF; Tsai, CM1
Ikeda, H; Koshiba, R1
Pawlicki, M; Rolski, J; Rysz, B; Utych, G; Wiczyńska, B; Zemełka, T1
Agelaki, S; Alexopoulos, A; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kosmas, C; Kouroussis, C; Malamos, N; Mavroudis, D; Rigatos, G; Sarra, E; Vlachonicolis, J1
Hada, M; Koshizuka, K; Mouri, N; Muto, S; Nakagomi, H; Serizawa, M; Tada, Y; Takano, K1
Beer, TM; Bubalo, JS1
Bischoff, J; Forstpointner, R; Geuenich, S; Gutschow, K; Heinemann, V; Hiddemann, W; Kentenich, CH; Malekmohammadi, M; Sommer, H; Stemmler, HJ1

Reviews

4 review(s) available for docetaxel anhydrous and Alopecia

ArticleYear
Dermatological adverse events with taxane chemotherapy.
    European journal of dermatology : EJD, 2016, Oct-01, Volume: 26, Issue:5

    Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids

2016
The taxoids. Comparative clinical pharmacology and therapeutic potential.
    Drugs, 1998, Volume: 55, Issue:1

    Topics: Alopecia; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase I as Topic; Docetaxel; Female; Humans; Lung Neoplasms; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids

1998
[The effect of docetaxel on malignant tumors].
    Orvosi hetilap, 1998, Apr-12, Volume: 139, Issue:15

    Topics: Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Humans; Neutropenia; Paclitaxel; Remission Induction; Taxoids

1998
Complications of chemotherapy for prostate cancer.
    Seminars in urologic oncology, 2001, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Docetaxel; Gastrointestinal Diseases; Humans; Male; Mitoxantrone; Nervous System Diseases; Paclitaxel; Prednisone; Prostatic Neoplasms; Taxoids

2001

Trials

51 trial(s) available for docetaxel anhydrous and Alopecia

ArticleYear
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023, Apr-17, Volume: 31, Issue:5

    Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Hair; Humans; Hypothermia, Induced; Neoplasms; Paclitaxel; Registries; Scalp

2023
Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Breast cancer research and treatment, 2018, Volume: 167, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Animals; Breast Neoplasms; Carboplatin; Docetaxel; Female; Humans; Hypothermia, Induced; Induction Chemotherapy; Middle Aged; Paclitaxel; Quality of Life; Scalp; Taxoids; Trastuzumab

2018
A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.
    Oncology research and treatment, 2019, Volume: 42, Issue:5

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Middle Aged; Nausea; Neoadjuvant Therapy; Neutropenia; Pilot Projects; Polyethylene Glycols; Stomatitis; Treatment Outcome

2019
The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial.
    The Journal of international medical research, 2019, Volume: 47, Issue:6

    Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Middle Aged; Nausea; Prognosis; Prospective Studies; Protective Agents; Survival Rate; Vomiting

2019
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:9

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Humans; Hypothermia, Induced; Induction Chemotherapy; Male; Middle Aged; Neoplasms; Palliative Care; Prospective Studies; Risk Reduction Behavior; Scalp; Taxoids

2013
Efficacy of nimotuzumab combined with docetaxel-cisplatin-fluorouracil regimen in treatment of advanced oral carcinoma.
    Cell biochemistry and biophysics, 2014, Volume: 68, Issue:1

    Topics: Aged; Aged, 80 and over; Alopecia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinoma; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intravenous; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoplasm Staging; Taxoids; Treatment Outcome

2014
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Genetic Predisposition to Disease; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Single Nucleotide; Stomach Neoplasms; Taxoids; Treatment Outcome

2015
Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypothermia, Induced; Male; Middle Aged; Neoplasms; Outcome Assessment, Health Care; Prospective Studies; Scalp; Taxoids

2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Clinical breast cancer, 2017, Volume: 17, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Quality of Life; Receptor, ErbB-2; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

2017
[Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:7

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult

2008
Poor survival outcome of docetaxel every three weeks plus prednisone for treatment of patients with hormone-refractory metastatic prostate cancer.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:3

    Topics: Aged; Alopecia; Anemia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Prednisone; Prospective Studies; Prostatic Neoplasms; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome

2010
The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg/m²) in Japanese patients with advanced or recurrent solid tumors.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:9

    Topics: Aged; Alopecia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Appetite; Asian People; Constipation; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Severity of Illness Index; Taxoids; Treatment Outcome; Xanthones

2011
Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:12

    Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasms; Patient Satisfaction; Scalp Dermatoses; Taxoids; Time Factors; Treatment Outcome

2012
[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Premenopause; Radiotherapy, Adjuvant; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vomiting

2012
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Mucositis; Nausea; Prospective Studies; Radiotherapy; Taxoids; Treatment Outcome

2013
The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    European journal of cancer care, 2003, Volume: 12, Issue:2

    Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Hypothermia, Induced; Paclitaxel; Taxoids; Treatment Outcome

2003
Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.
    Lung, 2004, Volume: 182, Issue:1

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophagitis; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Premedication; Remission Induction; Stomatitis; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

2004
Factors predicting docetaxel-related toxicity: experience at a single institution.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Health Status; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Regression Analysis; Stomach Neoplasms; Taxoids; Vomiting

2004
[Results of docetaxel therapy in patients with relapsed ovarian cancer].
    Magyar onkologia, 2005, Volume: 49, Issue:1

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Taxoids; Treatment Outcome

2005
[Bi-weekly chemotherapy with medium-dose docetaxel for advanced and recurrent breast cancers (The 15th study of Keiji Breast Cancer Study Group)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Adult; Aged; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Floxuridine; Humans; Middle Aged; Neoplasm Recurrence, Local; Taxoids

2005
[Evaluation of a combination chemotherapy with docetaxel and nedaplatin for patients with oral squamous cell carcinomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Taxoids

2005
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:6

    Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome

2006
[A randomized control clinical trial of Euruikang (docetaxel) in treatment of advanced non-small cell lung cancer (NSCLC)].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Remission Induction; Taxoids; Young Adult

2006
[Docetaxel in the treatment of advanced breast cancer ].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Remission Induction; Taxoids; Treatment Outcome; Vomiting

2006
[Randomized controlled trial of two kinds of home-produced docetaxel in China for advanced breast cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Disease-Free Survival; Docetaxel; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Taxoids

2006
[Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Quality of Life; Taxoids

2007
Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
    Investigational new drugs, 2008, Volume: 26, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Fatigue; Humans; Hypocalcemia; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Zoledronic Acid

2008
Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5

    Topics: Aged; Alopecia; Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Feasibility Studies; Humans; Japan; Leukopenia; Male; Middle Aged; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome

2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:9

    Topics: Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal; Carcinoma, Lobular; Deoxycytidine; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Liver Neoplasms; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Taxoids; Thymidine Phosphorylase; Treatment Outcome; Up-Regulation

2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
    British journal of cancer, 2008, May-06, Volume: 98, Issue:9

    Topics: Adult; Aged; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Belgium; Boronic Acids; Bortezomib; Breast Neoplasms; Breast Neoplasms, Male; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neutropenia; Prospective Studies; Pyrazines; Spain; Taxoids; Treatment Outcome; United Kingdom; Vomiting

2008
[Late phase II trial of RP56976 (Docetaxel) in patients with non-small-cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Paclitaxel; Taxoids; Vomiting

1995
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Paclitaxel; Taxoids

1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Europe; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Taxoids

1994
[An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids

1994
[An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14

    Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Paclitaxel; Remission Induction; Taxoids

1994
[Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15

    Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids; Treatment Outcome

1994
[Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Fever; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Taxoids; Treatment Outcome

1994
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15

    Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Asthenia; Bone Neoplasms; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Treatment Outcome

1994
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
    British journal of cancer, 1996, Volume: 73, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Medullary; Carcinoma, Papillary; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Toxicity Tests

1996
Phase II study of docetaxel in advanced soft tissue sarcomas.
    American journal of clinical oncology, 1996, Volume: 19, Issue:6

    Topics: Adult; Aged; Alopecia; Anorexia; Antiemetics; Antineoplastic Agents, Phytogenic; Cause of Death; Dexamethasone; Diarrhea; Diphenhydramine; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Leukopenia; Male; Middle Aged; Nausea; Paclitaxel; Patient Selection; Premedication; Remission Induction; Sarcoma; Taxoids; Uterine Neoplasms; Vomiting

1996
Effectiveness of cold cap in the prevention of docetaxel-induced alopecia.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:2

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Cryotherapy; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Taxoids

1997
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting

1998
[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting, Anticipatory

1999
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Alopecia; Antineoplastic Agents, Phytogenic; Area Under Curve; Aspartate Aminotransferases; Breast Neoplasms; Diarrhea; Docetaxel; Fatigue; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mouth Mucosa; Neoplasms; Neutropenia; Paclitaxel; Stomatitis; Taxoids; Time Factors

2000
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:6

    Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cryotherapy; Docetaxel; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Scalp; Taxoids

2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.
    British journal of cancer, 2000, Volume: 83, Issue:1

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Biotransformation; Capecitabine; Carboxylic Ester Hydrolases; Deamination; Deoxycytidine; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Fever; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Paronychia; Prodrugs; Remission Induction; Taxoids; Treatment Outcome

2000
A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
    Japanese journal of clinical oncology, 2000, Volume: 30, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Taxoids

2000
[Evaluation of efficacy and toxicity of docetaxel (Taxotere) in patients with advanced mammary gland cancer].
    Przeglad lekarski, 2001, Volume: 58, Issue:2

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Treatment Outcome

2001
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:6

    Topics: Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mitoxantrone; Nausea; Neutropenia; Paclitaxel; Sepsis; Survival Rate; Taxoids

2001
[Effect of weekly docetaxel in patients with recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pilot Projects; Taxoids

2001
Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome

2001

Other Studies

26 other study(ies) available for docetaxel anhydrous and Alopecia

ArticleYear
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Current oncology (Toronto, Ont.), 2022, 09-30, Volume: 29, Issue:10

    Topics: Adult; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Humans; Paclitaxel; Prospective Studies; Scalp; Taxoids

2022
Transfer Learning for Early Prediction of Adverse Drug Reactions: Docetaxel and Alopecia in Breast Cancer as a Case Study.
    Studies in health technology and informatics, 2023, May-18, Volume: 302

    Topics: Adverse Drug Reaction Reporting Systems; Alopecia; Breast Neoplasms; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Machine Learning

2023
CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia.
    EMBO molecular medicine, 2019, Volume: 11, Issue:10

    Topics: Alopecia; Antineoplastic Agents; Bridged-Ring Compounds; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Docetaxel; Humans; Keratinocytes; Models, Theoretical; Organ Culture Techniques; Paclitaxel; Piperazines; Protein Kinase Inhibitors; Pyridines; Stem Cells; Taxoids

2019
Definitive alopecia post-docetaxel.
    The breast journal, 2020, Volume: 26, Issue:4

    Topics: Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Paclitaxel; Taxoids

2020
Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature.
    International journal of dermatology, 2020, Volume: 59, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Hand-Foot Syndrome; Humans; Hyperpigmentation; Longitudinal Studies; Middle Aged; Mucositis; Nail Diseases; Prospective Studies; Review Literature as Topic; Skin Diseases

2020
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.
    JAMA dermatology, 2020, 09-01, Volume: 156, Issue:9

    Topics: Adult; Age Factors; Alopecia; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Biopsy; Breast Neoplasms; Case-Control Studies; Docetaxel; Dose-Response Relationship, Drug; Enhancer Elements, Genetic; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genome-Wide Association Study; Hair Follicle; Humans; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Risk Factors

2020
Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases.
    Bulletin du cancer, 2021, Volume: 108, Issue:3

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Digestive System Diseases; Docetaxel; Fatigue; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Nail Diseases; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tunisia

2021
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel.
    Clinical genitourinary cancer, 2015, Volume: 13, Issue:4

    Topics: Alopecia; Clinical Trials as Topic; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Dysgeusia; Humans; Male; Nail Diseases; Peripheral Nervous System Diseases; Prospective Studies; Prostatic Neoplasms; Retrospective Studies; Taxoids

2015
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Clinical breast cancer, 2015, Volume: 15, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Female; Follow-Up Studies; Hair; Humans; Hypothermia, Induced; Middle Aged; Prospective Studies; Scalp; Taxoids; Treatment Outcome

2015
Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer.
    The British journal of dermatology, 2009, Volume: 160, Issue:4

    Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Taxoids

2009
Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    The American Journal of dermatopathology, 2011, Volume: 33, Issue:4

    Topics: Alopecia; Antineoplastic Agents; Busulfan; Cisplatin; Dermis; Diagnosis, Differential; Docetaxel; Etoposide; Female; Hair; Humans; Male; Neoplasms; Taxoids

2011
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Ficusin; Fluorouracil; Humans; Middle Aged; Minoxidil; Prospective Studies; Spironolactone; Taxoids; Ultraviolet Therapy; Vitamins

2012
Calcitriol and alopecia--is it the hair apparent?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-15, Volume: 21, Issue:10

    Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Docetaxel; Humans; Male; Neoplasm Metastasis; Paclitaxel; Prostatic Neoplasms; Taxoids

2003
[Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12

    Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Stomach Neoplasms; Taxoids

2003
Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:3

    Topics: Aged; Alopecia; Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Feasibility Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Taxoids

2004
[Docetaxel and carboplatin for epithelial ovarian cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Evaluation; Drug Hypersensitivity; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neutropenia; Ovarian Neoplasms; Taxoids

2004
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
    Urology, 2005, Volume: 65, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alopecia; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Estramustine; Humans; Imidazoles; Life Tables; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Orchiectomy; Pain; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome; Zoledronic Acid

2005
[Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neutropenia; Pilot Projects; Taxoids

2006
[Examination of the safety of docetaxel/cyclophosphamide combination therapy for advanced recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10

    Topics: Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Skin Neoplasms; Stomatitis; Taxoids

2006
[Efficacy and toxicity of combination treatment with epirubicin (EPI) plus docetaxel (DOC) in advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:11

    Topics: Adult; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Taxoids

2006
[The efficacy and safety of docetaxel for elderly advanced breast cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3

    Topics: Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Edema; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Remission Induction; Taxoids

2007
Docetaxel-induced alopecia can be prevented.
    Lancet (London, England), 1995, Aug-05, Volume: 346, Issue:8971

    Topics: Alopecia; Antineoplastic Agents, Phytogenic; Bandages; Cold Temperature; Docetaxel; Head; Humans; Paclitaxel; Taxoids

1995
Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases.
    Cancer, 1995, Jul-01, Volume: 76, Issue:1

    Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Edema; Female; Humans; Leg; Leiomyosarcoma; Lung Neoplasms; Male; Melanoma; Middle Aged; Paclitaxel; Scleroderma, Localized; Taxoids

1995
[Breast cancer with liver metastasis responsive to docetaxel: case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

    Topics: Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids

1998
[Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Taxoids

1999
[Efficacy of docetaxel for anthracycline-resistant metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:5

    Topics: Alopecia; Anthracyclines; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Salvage Therapy; Survival Rate; Taxoids

2001